Cargando…

New Strategies and In Vivo Monitoring Methods for Stem Cell-Based Anticancer Therapies

Cancer is a devastating disease and the second cause of death in the developed world. Despite significant advances in recent years, such as the introduction of targeted therapies such as receptor tyrosine kinase inhibitors and immunotherapy, current approaches are insufficient to stop the advance of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ping, Aguirre, Aitor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276456/
https://www.ncbi.nlm.nih.gov/pubmed/30581474
http://dx.doi.org/10.1155/2018/7315218
_version_ 1783378015615451136
author Wang, Ping
Aguirre, Aitor
author_facet Wang, Ping
Aguirre, Aitor
author_sort Wang, Ping
collection PubMed
description Cancer is a devastating disease and the second cause of death in the developed world. Despite significant advances in recent years, such as the introduction of targeted therapies such as receptor tyrosine kinase inhibitors and immunotherapy, current approaches are insufficient to stop the advance of the disease and many cancer types remain largely intractable. In this review, we describe the latest and most revolutionary stem cell-based approaches for the treatment of cancer. We also summarize the emerging imaging modalities being applied for monitoring anticancer stem cell therapy success and discuss the implications of these novel technologies for precision medicine.
format Online
Article
Text
id pubmed-6276456
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-62764562018-12-23 New Strategies and In Vivo Monitoring Methods for Stem Cell-Based Anticancer Therapies Wang, Ping Aguirre, Aitor Stem Cells Int Review Article Cancer is a devastating disease and the second cause of death in the developed world. Despite significant advances in recent years, such as the introduction of targeted therapies such as receptor tyrosine kinase inhibitors and immunotherapy, current approaches are insufficient to stop the advance of the disease and many cancer types remain largely intractable. In this review, we describe the latest and most revolutionary stem cell-based approaches for the treatment of cancer. We also summarize the emerging imaging modalities being applied for monitoring anticancer stem cell therapy success and discuss the implications of these novel technologies for precision medicine. Hindawi 2018-11-15 /pmc/articles/PMC6276456/ /pubmed/30581474 http://dx.doi.org/10.1155/2018/7315218 Text en Copyright © 2018 Ping Wang and Aitor Aguirre. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Wang, Ping
Aguirre, Aitor
New Strategies and In Vivo Monitoring Methods for Stem Cell-Based Anticancer Therapies
title New Strategies and In Vivo Monitoring Methods for Stem Cell-Based Anticancer Therapies
title_full New Strategies and In Vivo Monitoring Methods for Stem Cell-Based Anticancer Therapies
title_fullStr New Strategies and In Vivo Monitoring Methods for Stem Cell-Based Anticancer Therapies
title_full_unstemmed New Strategies and In Vivo Monitoring Methods for Stem Cell-Based Anticancer Therapies
title_short New Strategies and In Vivo Monitoring Methods for Stem Cell-Based Anticancer Therapies
title_sort new strategies and in vivo monitoring methods for stem cell-based anticancer therapies
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276456/
https://www.ncbi.nlm.nih.gov/pubmed/30581474
http://dx.doi.org/10.1155/2018/7315218
work_keys_str_mv AT wangping newstrategiesandinvivomonitoringmethodsforstemcellbasedanticancertherapies
AT aguirreaitor newstrategiesandinvivomonitoringmethodsforstemcellbasedanticancertherapies